Note: Ingredients listed on restricted chemical lists
EC/CAS
204-800-2/126-73-8
Name of the chemical
Tributyl phosphate
Concentration
<1.0%
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
1.0%
General Information
Revision date
2015-04-23
Product name
CEDIA CsA II assay
Product Synonyms
100147 CEDIA® Cyclosporine PLUS - EA reagent, ED reagent
1.2.1 Relevant identified uses
In vitro diagnostic kit. Contains multiple lyophilized powder reagents packaged as separate vials
Icons in SDS
Company Information
company name
Microgenics Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
techservice.mgc@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) Respiratory sensitizer - Category 1. Skin sensitizer - Category 1. Aquatic toxicity 1272/2008 [GHS] (chronic) - Category 3. Mixture not yet fully tested. Directive 67/548/EEC or Xn - R42 (Respiratory Sens.), R43 (Skin Sens.); R52/53. Mixture not yet fully 1999/45/EC tested.
2.2 Label elements
SECTION 2 - HAZARDS IDENTIFICATION …continued
Signal word
Danger Danger US Hazard overview May cause allergic respiratory reaction. May cause allergic skin reaction. May be harmful to aquatic life with long lasting effects. Mixture not yet fully tested. This product contains bovine serum albumin, which has been associated with occupational sensitization. Note This mixture is classified as hazardous according to Directive 1999/45/EC, Regulation (EC) No 1272/2008 (EU CLP) and applicable US regulations. The pharmacological, toxicological, and ecological properties of this mixture have not been fully characterized. The CLP/GHS classifications are based on Regulation (EC) 1272/2008. The EU symbol/indicator of danger, R Phrases and Safety Advice are based on Directive 1999/45/EC.
CLP CLASSIFICATION
H317 - May cause allergic skin reaction. H334 - May cause allergy or asthma
Hazard statements
symptoms or breathing difficulties if inhaled. H412 - Harmful to aquatic life with long lasting effects. EUH032 - Contact with acids liberates very toxic gas. CLP/GHS precautionary P261 - Avoid breathing dust/mist/vapor/spray. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective gloves/eye protection/face protection. P285 - In case of inadequate ventilation wear respiratory protection. P302 + P352 - If on skin Wash with plenty of soap and water. P304 + P341 - IF INHALED If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P363 - Wash contaminated clothing before reuse. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations. EU symbol/indication of danger Xn - Harmful Risk (R) Phrase(s) R42/43 - May cause sensitization by inhalation and skin contact. R52/53 - Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. R32 - Contact with acids liberates very toxic gas.
Precautionary statements
S2 - Keep out of reach of children. S23 - Do not breathe dust/mist/vapors/spray. S24 - Avoid contact with skin. S29 - Do not empty into drains. S37 - Wear suitable protective gloves. S46 - If swallowed, seek medical advice immediately and show this container or label. S50 - Do not mix with acids. S63 - In case of accident by inhalation: remove casualty to fresh air and keep at rest.
2.3 Other hazards
No data specific for the mixture were identified. The mixture contains bovine serum albumin which has been associated with occupational sensitization. Material produced in compliance with USDA and/or CPMP/BWP/1230/98 (Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Medicinal Products). This is a CPMP/ BWP/1230/98 Category IV material: it does not contain nor is it derived from specified risk materials as defined in Commission decision 97/534/EC (or successive amendments). SECTION 2 - HAZARDS IDENTIFICATION …continued Other hazards …continued Because the mixture contains a protein, it may cause an allergic skin or respiratory reaction (e.g., potential to cause anaphylaxis). In a workplace setting, the likelihood of systemic effects following accidental ingestion is low, due to the rapid breakdown of proteins in the digestive tract.